These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 19321874

  • 21. Management of systemic vasculitis.
    Langford CA.
    Best Pract Res Clin Rheumatol; 2001 Jun; 15(2):281-97. PubMed ID: 11469822
    [Abstract] [Full Text] [Related]

  • 22. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
    Harper L, Savage CO.
    Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
    [Abstract] [Full Text] [Related]

  • 23. Azathioprine-associated hypersensitivity reaction in a patient with Churg Strauss vasculitis.
    Lehmann P, Fleck M, Schoelmerich J, Haerle P.
    J Clin Rheumatol; 2010 Aug; 16(5):242-3. PubMed ID: 20661072
    [No Abstract] [Full Text] [Related]

  • 24. [Wegener's granulomatosis in 2 adolescents].
    van der Aa LB, van der Heide M, Sprikkelman AB, Brinkhorst G, Tytgat GA, van den Berg JM.
    Ned Tijdschr Geneeskd; 2007 Jul 07; 151(27):1522-6. PubMed ID: 17763812
    [Abstract] [Full Text] [Related]

  • 25. [Immunosuppressive effect of cytostatics in the clinic].
    Gerhartz H.
    Schweiz Rundsch Med Prax; 1970 Jul 21; 59(29):1049-52. PubMed ID: 5512654
    [No Abstract] [Full Text] [Related]

  • 26. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.
    Nephrol Dial Transplant; 2004 Jun 21; 19(6):1403-11. PubMed ID: 15069175
    [Abstract] [Full Text] [Related]

  • 27. Meningeal involvement in Wegener's granulomatosis.
    Al Dhanhani A, Macaulay R, Maloney B, Hanly JG.
    J Rheumatol; 2006 Feb 21; 33(2):364-7. PubMed ID: 16465672
    [Abstract] [Full Text] [Related]

  • 28. Azathioprine hypersensitivity: report of two cases and review of the literature.
    Sinico RA, Sabadini E, Borlandelli S, Cosci P, Di Toma L, Imbasciati E.
    J Nephrol; 2003 Feb 21; 16(2):272-6. PubMed ID: 12768076
    [Abstract] [Full Text] [Related]

  • 29. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS, Slot MC, Stegeman CA.
    N Engl J Med; 2003 Nov 20; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract] [Full Text] [Related]

  • 30. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E.
    Dtsch Med Wochenschr; 2002 Sep 13; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract] [Full Text] [Related]

  • 31. [Wegener's granulomatosis: diagnosis and treatment].
    Vera-Lastra O, Olvera-Acevedo A, McDonal-Vera A, Pacheco-Ruelas M, Gayosso-Rivera JA.
    Gac Med Mex; 2009 Sep 13; 145(2):121-9. PubMed ID: 19518019
    [Abstract] [Full Text] [Related]

  • 32. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ.
    Am J Gastroenterol; 1996 Mar 13; 91(3):423-33. PubMed ID: 8633486
    [No Abstract] [Full Text] [Related]

  • 33. [Primary cutaneous manifestation of Wegener's granulomatosis].
    Bramsiepe I, Danz B, Heine R, Taube KM, Holzhausen HJ, Marsch WC, Fiedler E.
    Dtsch Med Wochenschr; 2008 Jul 13; 133(27):1429-32. PubMed ID: 18592451
    [Abstract] [Full Text] [Related]

  • 34. Just chronic sinusitis?
    McMahon NS, Cooper M, Iorember F, English R.
    Clin Pediatr (Phila); 2012 Nov 13; 51(11):1099-102. PubMed ID: 22893188
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of Wegener's granulomatosis with immunosuppressive agents. Description of renal ultrastructure.
    Aldo MA, Benson MD, Comerford FR, Cohen AS.
    Arch Intern Med; 1970 Aug 13; 126(2):298-305. PubMed ID: 5433070
    [No Abstract] [Full Text] [Related]

  • 36. Evidence-based management of ANCA vasculitis.
    Carruthers D, Sherlock J.
    Best Pract Res Clin Rheumatol; 2009 Jun 13; 23(3):367-78. PubMed ID: 19508944
    [Abstract] [Full Text] [Related]

  • 37. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D'Cruz D, Guillevin L, Harper L, Jayne D, Luqmani R, Mooney J, Scott D, BSR and BHPR Standards, Guidelines and Audit Working Group.
    Rheumatology (Oxford); 2007 Oct 13; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract] [Full Text] [Related]

  • 38. [Wegener-Klinger granulomatosis. Permanent remission by immunosuppressive polychemotherapy].
    Rossi F.
    Reumatismo; 1968 Oct 13; 20(2):157-68. PubMed ID: 5748165
    [No Abstract] [Full Text] [Related]

  • 39. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC, Tervaert JW, Boomsma MM, Stegeman CA.
    Arthritis Rheum; 2004 Apr 15; 51(2):269-73. PubMed ID: 15077271
    [Abstract] [Full Text] [Related]

  • 40. Thiopurinemethyltransferase (TPMT) genotype and TPMT activity in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: relation to azathioprine maintenance treatment and adverse effects.
    Stassen PM, Derks RP, Kallenberg CG, Stegeman CA.
    Ann Rheum Dis; 2009 May 15; 68(5):758-9. PubMed ID: 19366895
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.